# PubMed API Leads: Health Tech & Medical AI Companies

**Target Segment:** Health tech startups, clinical decision support tools, medical AI companies
**Product:** PubMed API (https://pubmed.built-simple.ai) - Medical/scientific literature search
**Generated:** 2026-01-31

---

## ðŸ”¥ðŸ”¥ðŸ”¥ NEW: Hot Lead Added 2026-02-07

### Sprinter Health ðŸ”¥ðŸ”¥
**Website:** https://sprinterhealth.com
**Description:** AI-powered home healthcare platform. Sends nurses to homes for lab draws, vitals, screenings. Expanding from 5 states (2023) to 22 states by summer 2025.
**Funding:** $125M total ($55M Series B in May 2025)
**HQ:** Menlo Park, CA
**Investors:** General Catalyst (lead), a16z Bio + Health, Google Ventures, Accel

| Role | Name | LinkedIn |
|------|------|----------|
| Co-founder & CEO | Max Cohen | Ex-VP Mobile at Oculus/Facebook |
| Co-founder & CTO | Cameron Behar | - |
| VP of People | Scott Fintzy | - |

**Why PubMed API:** Their AI platform optimizes clinical workflows and nurse schedules. Could integrate literature for clinical protocols, care gap identification, and evidence-based screening recommendations. "Growing the team significantly across clinical, engineering, AI and operations."

**Recent Hook:** $55M Series B closed May 2025. Expanding to 22 states. CEO says they're "doubling down on AI."

**Outreach Angle:** "As Sprinter Health scales to 22 states, PubMed API could power evidence-based clinical protocols for your home health workflows. We help similar healthcare AI platforms integrate literature search."

**Email Pattern:** firstname@sprinterhealth.com
**Website:** https://sprinterhealth.com

---

## High-Priority Leads

### 1. OpenEvidence
**Website:** https://www.openevidence.com
**Description:** AI copilot for doctors providing clinical decision support at point of care. Most widely used medical AI among US physicians. Partners with NEJM, JAMA, NCCN.
**Why PubMed API:** Their core product requires access to medical literature to power clinical recommendations.

| Role | Name | LinkedIn |
|------|------|----------|
| Founder & CEO | Daniel Nadler, PhD | (Harvard, TIME100 Most Influential in Health) |
| Contact | - | contact@openevidence.com |

---

### 2. Infermedica
**Website:** https://infermedica.com
**Description:** AI-powered symptom checker and virtual triage platform. 25M+ health checkups, 96% condition accuracy, 26 languages supported.
**Why PubMed API:** Evidence-based symptom assessment requires medical literature integration.

| Role | Name | LinkedIn |
|------|------|----------|
| CEO | Piotr Orzechowski | https://linkedin.com/in/piotr-orzechowski |
| Chief Architect | PaweÅ‚ Iwaszko | - |
| VP of Engineering | Krzysztof GruszczyÅ„ski | - |
| VP of Product | Patryk Sudnik | - |
| Contact | - | contact@infermedica.com |

---

### 3. Ada Health
**Website:** https://about.ada.com
**Description:** AI symptom assessment platform with 14M+ users, 34M+ assessments. Clinical intelligence for automated care navigation.
**Why PubMed API:** Evidence-based diagnostic recommendations need literature backing.

| Role | Name | LinkedIn |
|------|------|----------|
| Co-founder & CMO | Dr. Claire Novorol | - |
| SVP Medical Product | Ewelina TÃ¼rk | - |
| Director of Medical Affairs | Dr. Adel Baluch | - |
| Contact | - | https://about.ada.com/contact |

---

### 4. Abridge
**Website:** https://www.abridge.com
**Description:** Generative AI for healthcare - transforms clinical conversations into insights. Used by major health systems.
**Why PubMed API:** Clinical documentation and insights benefit from literature references.

| Role | Name | LinkedIn |
|------|------|----------|
| CEO & Co-Founder | Shiv Rao, MD | - |
| CTO & Co-Founder | Zack Lipton, PhD | - |
| COO | Julia Chou | - |
| Chief Commercial Officer | Brian Wilson | - |
| CFO | Sagar Sanghvi | - |

---

### 5. Hippocratic AI
**Website:** https://hippocraticai.com
**Description:** Safety-focused healthcare AI agents. Building generative AI for clinical abundance.
**Why PubMed API:** Medical AI agents need reliable literature access for evidence-based responses.

| Role | Name | LinkedIn |
|------|------|----------|
| CEO & Co-Founder | Munjal Shah | (Former CEO, Like.com - sold to Google) |
| COO | Dan Kendall | (Former COO, El Camino Health) |
| Chief Product Officer | Vishal (Co-Founder) | - |
| Chief Science Officer | Subho (Co-Founder) | - |
| Contact | - | https://hippocraticai.com/contact |

---

### 6. Viz.ai
**Website:** https://www.viz.ai
**Description:** AI-powered care coordination for stroke, cardiovascular conditions. FDA-cleared, used by major health systems.
**Why PubMed API:** Clinical decision support and research validation require literature access.

| Role | Name | LinkedIn |
|------|------|----------|
| CEO & Co-Founder | Chris Mansi, MD, MBA | https://linkedin.com/in/chrismansimd/ |
| COO | Jieun Choe | https://linkedin.com/in/jieunwc/ |
| VP R&D | Oded Cohen | https://linkedin.com/in/oded-cohen-78678a17 |
| CFO | Mike Herring | https://linkedin.com/in/mikeherring |
| Chief Clinical Officer | Andrew M. Ibrahim MD | https://linkedin.com/in/andrewibrahim/ |
| CMO | Timothy N. Showalter, MD | https://linkedin.com/in/tim-showalter-08616518/ |

---

### 7. Aidoc
**Website:** https://www.aidoc.com
**Description:** AI radiology platform - FDA-cleared algorithms for acute anomaly detection. Enterprise clinical AI.
**Why PubMed API:** Clinical validation and evidence-based AI requires literature integration.

| Role | Name | LinkedIn |
|------|------|----------|
| Founded by | 4 Talpiot officers (Israeli Defense Forces) | - |
| Contact | - | https://www.aidoc.com/contact |

---

### 8. Truveta
**Website:** https://www.truveta.com
**Description:** EHR data and analytics from 130M+ patients. Real-world evidence for clinical research. Backed by major health systems.
**Why PubMed API:** Research platform would benefit from integrated literature search.

| Role | Name | LinkedIn |
|------|------|----------|
| CEO & Co-Founder | Terry Myerson | (Former EVP, Microsoft) |
| CTO & Co-Founder | Jay Nanduri | (Former Microsoft Technical Fellow) |
| CMO & Co-Founder | Dr. Ryan Ahern | - |
| Chief Growth Officer | Sally Omidvar | - |
| President & CSO | Johnathan Lancaster, MD, PhD | - |
| Contact | - | https://www.truveta.com/contact |

---

### 9. Tempus
**Website:** https://www.tempus.com
**Description:** AI platform for precision medicine in oncology. Data-driven diagnostics and research.
**Why PubMed API:** Cancer research and clinical decision support require literature access.

| Role | Name | LinkedIn |
|------|------|----------|
| Founder & CEO | Eric Lefkofsky | - |
| Contact | - | https://www.tempus.com/contact |

---

### 10. Flatiron Health
**Website:** https://flatiron.com
**Description:** Oncology-focused real-world evidence platform. Pioneer in oncology data and analytics. Roche affiliate.
**Why PubMed API:** Oncology research and evidence generation require literature integration.

| Role | Name | LinkedIn |
|------|------|----------|
| Contact | - | https://flatiron.com/contact |

---

### 11. Evidation
**Website:** https://evidation.com
**Description:** Real-world health data platform with millions of members. 175+ virtual studies, 70+ peer-reviewed publications.
**Why PubMed API:** Research platform publishing in scientific literature would benefit from integration.

| Role | Name | LinkedIn |
|------|------|----------|
| Contact | - | https://evidation.com/contact |

---

### 12. Cohere Med
**Website:** https://cohere-med.com
**Description:** Clinical AI for sepsis detection, mortality prediction, cardiac decompensation. Duke University partnership.
**Why PubMed API:** Clinical prediction models benefit from literature-backed evidence.

| Role | Name | LinkedIn |
|------|------|----------|
| Co-founder & CEO | Ajit Thomas | https://linkedin.com/in/ajit-thomas-30429b8/ |
| Co-founder & CPO | Srikanth Muthya | https://linkedin.com/in/srikanthmuthya/ |
| Co-founder | Renjith Nair | https://linkedin.com/in/renjith-s-nair/ |
| Advisor | Michael Gao (Duke) | https://linkedin.com/in/michael-gao-88074662/ |
| Contact | - | https://cohere-med.com/contact |

---

### 13. Paige.ai
**Website:** https://www.paige.ai
**Description:** AI for cancer diagnostics and pathology. Foundation models for computational pathology. FDA-cleared solutions.
**Why PubMed API:** Cancer research and diagnostic validation require literature access.

| Role | Name | LinkedIn |
|------|------|----------|
| Contact | - | https://www.paige.ai/contact |

---

### 14. Suki AI
**Website:** https://www.suki.ai
**Description:** AI voice assistant for clinical documentation. Integrates with EHRs including Epic.
**Why PubMed API:** Clinical documentation could benefit from literature references.

| Role | Name | LinkedIn |
|------|------|----------|
| Contact | - | support@suki.ai |

---

### 15. Health Gorilla
**Website:** https://www.healthgorilla.com
**Description:** Health data network - only dual-designated QHIN & QHIO. National interoperability infrastructure.
**Why PubMed API:** Health data platform could integrate literature for research.

| Role | Name | LinkedIn |
|------|------|----------|
| Contact | - | https://www.healthgorilla.com/contact |

---

### 16. Nabla
**Website:** https://www.nabla.com
**Description:** AI copilot for clinical documentation. Ambient AI for physicians.
**Why PubMed API:** Clinical documentation enrichment with evidence references.

| Role | Name | LinkedIn |
|------|------|----------|
| LinkedIn | - | https://linkedin.com/company/nablahq/ |
| Contact | - | contact@nabla.com |

---

### 17. Buoy Health
**Website:** https://www.buoyhealth.com
**Description:** AI-powered symptom checker and health navigation platform.
**Why PubMed API:** Evidence-based symptom assessment requires literature backing.

| Role | Name | LinkedIn |
|------|------|----------|
| Contact | - | https://www.buoyhealth.com/contact |

---

### 18. Clear Labs
**Website:** https://www.clearlabs.com
**Description:** Automated NGS platform for diagnostics - infectious disease, oncology. FDA-cleared.
**Why PubMed API:** Clinical research and diagnostic validation require literature access.

| Role | Name | LinkedIn |
|------|------|----------|
| CEO & Co-Founder | Sasan Amini, PhD | (Princeton, former Illumina) |
| Chief Commercial Officer | Edward Fan | - |
| VP Engineering | Henrik Gehrmann | - |
| Contact | - | https://www.clearlabs.com/contact |

---

### 19. Komodo Health
**Website:** https://www.komodohealth.com
**Description:** Healthcare analytics platform - AI-powered real-world data. Marmot AI co-pilot.
**Why PubMed API:** Research publications and HEOR studies require literature integration.

| Role | Name | LinkedIn |
|------|------|----------|
| Contact | - | https://www.komodohealth.com/contact |

---

### 20. Merative (formerly IBM Watson Health)
**Website:** https://www.merative.com
**Description:** Clinical decision support (Micromedex, DynaMedex), healthcare data analytics (Truven), medical imaging (Merge).
**Why PubMed API:** Major CDS provider - natural integration point for literature search.

| Role | Name | LinkedIn |
|------|------|----------|
| Contact | - | https://www.merative.com/contact |

---

## Outreach Strategy Recommendations

### Messaging Angles:
1. **For CDS companies:** "Enhance your clinical recommendations with real-time PubMed literature search"
2. **For AI platforms:** "Ground your AI responses in peer-reviewed medical evidence"
3. **For research platforms:** "Streamline literature integration in your research workflows"

### Key Value Props:
- Fast, reliable API access to PubMed literature
- Easy integration for existing health tech products
- Evidence-based medicine compliance
- Reduces development time for literature search features

### Decision Maker Priorities:
- **CTOs/VPs Engineering:** API reliability, documentation, integration ease
- **CPOs:** Feature differentiation, user value
- **CMOs:** Clinical accuracy, evidence standards
- **CEOs:** Competitive advantage, speed to market

---

## Notes
- Contact info gathered from public websites
- LinkedIn profiles where available
- Many companies have contact forms rather than direct emails
- Consider warm introductions via investor networks (many share investors)
